PRESS RELEASE published on 05/23/2025 at 08:05, 1 year 5 months ago Proposition à la prochaine Assemblée Générale Mixte du 27 juin 2025 d'une autorisation pour augmenter la capacité d'émission de nouveaux titres jusque 200 millions d'euros. ONE EXPERIENCE soumettra lors de son Assemblée Générale Mixte du 27 juin 2024 une résolution pour augmenter la capacité d'émission de nouveaux titres à 200 millions d'euros, avec projet d'attribution gratuite de BSA à tous les actionnaires Augmentation De Capital Assemblée Générale Mixte EuroLand Corporate ONE EXPERIENCE BSA
PRESS RELEASE published on 05/23/2025 at 08:00, 1 year 5 months ago Transaction in Own Shares Molten Ventures Plc (GROW) announces transaction in own shares. Numis Securities Limited purchased 50,000 Ordinary Shares on 22 May 2025 as part of the share repurchase program Molten Ventures Plc Numis Securities Limited GROW Transaction Share Repurchase Program
PRESS RELEASE published on 05/23/2025 at 08:00, 1 year 5 months ago Aquis Stock Exchange: Application for Admission Announcement Aquis Stock Exchange: Ajax Resources plc announces application for admission to the Aquis Growth Market with a focus on mineral exploration, including Copper, Gold, Zinc, Uranium, and Lead. Acquisition of Puna Metals S.A. in Argentina finalized Mineral Exploration Copper Aquis Stock Exchange Argentina Ajax Resources Plc
REGULATED PRESS RELEASE published on 05/23/2025 at 08:00, 1 year 5 months ago KLARSEN : Initiation de couverture de la valeur par CHAMPEIL SA KLARSEN annonce l'initiation de couverture de son titre par CHAMPEIL SA dans le domaine du data marketing pour accroître sa visibilité sur les marchés financiers Klarsen Data Marketing Analyse Financière Initiation De Couverture Champeil SA
PRESS RELEASE published on 05/23/2025 at 08:00, 1 year 5 months ago Nomination de Michèle Lesieur en tant que Présidente du Conseil d'administration de Prodways Group Nomination de Michèle Lesieur comme Présidente du Conseil d'Administration chez Prodways Group renforçant l'indépendance et la gouvernance. Évolution suite à la réorganisation actionnariale Gouvernance Nomination Prodways Group Indépendance Michèle Lesieur
PRESS RELEASE published on 05/23/2025 at 08:00, 1 year 5 months ago Michèle Lesieur Appointed Chairperson of the Prodways Group Board of Directors Prodways Group appoints Michèle Lesieur as Chairperson of the Board of Directors, enhancing independence and strategic implementation. The Gorgé family maintains governance involvement Board Of Directors Governance Prodways Group Chairperson Michèle Lesieur
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 5 months ago AB Science : AB Science a réalisé avec succès une augmentation de capital de 1,8 million d’euros renforçant sa trésorerie et couvrant ses besoins de financement. Découvrez les détails dans ce communiqué de presse Augmentation De Capital Trésorerie AB Science Masitinib AB8939
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 5 months ago AB Science announces the settlement delivery of its latest capital increase for €1.8 million AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases Healthcare Industry Financial News Capital Increase Drug Development AB Science
REGULATED PRESS RELEASE published on 05/23/2025 at 07:30, 1 year 5 months ago Vif succès de l’augmentation de capital de NFL Biosciences avec une levée plafonnée à 3 millions d’euros NFL Biosciences annonce une levée de fonds réussie de 3 millions d'euros pour financer son candidat médicament contre l'addiction au tabac. Allocation des fonds pour une étude de Phase 3 de NFL-101 NFL Biosciences NFL-101 Levée De Fonds Phase 3 Addiction Au Tabac
REGULATED PRESS RELEASE published on 05/23/2025 at 07:30, 1 year 5 months ago NFL Biosciences announces the success of its capital increase capped at €3 million NFL Biosciences successfully completes €3 million capital increase with oversubscription, involving international and French investors; plans Phase 3 clinical trial for smoking cessation drug NFL-101 NFL Biosciences Investors Capital Increase Smoking Cessation Phase 3 Clinical Trial
Published on 11/03/2026 at 17:30, 2 hours 18 minutes ago Western Raises Gross Proceeds of Over $55.8 Million on Closing of Previously Announced Private Placement
Published on 11/03/2026 at 15:30, 4 hours 18 minutes ago Murchison Minerals Announces $1 Million Non-Brokered Private Placement
Published on 11/03/2026 at 15:05, 4 hours 43 minutes ago ACCESS Newswire to Host Third Quarter Earnings Conference Call on November 10, 2026
Published on 11/03/2026 at 14:31, 5 hours 17 minutes ago First Breach Adds Inspection Equipment and Secures Strategic Supply Agreements to Support Ammunition Production
Published on 11/03/2026 at 14:00, 5 hours 48 minutes ago Global Education Communities Corp. Provides Corporate Update on Student Housing Portfolio and Development Projects
Published on 11/03/2026 at 19:30, 18 minutes ago Africa and Caribbean trade potential could reach $1.65 billion annually by 2030: International Trade Centre (ITC)-Afreximbank report
Published on 11/03/2026 at 17:45, 2 hours 3 minutes ago BILENDI: Retour à une légère croissance du chiffre d’affaires au 3ème trimestre 2026
Published on 11/03/2026 at 17:45, 2 hours 3 minutes ago BILENDI: Bilendi returns to slight revenue growth in Q3 2026
Published on 11/03/2026 at 18:39, 1 hour 9 minutes ago NRJ Group - Information relative aux droits de vote au 31.10.2026 (French & English)
Published on 11/03/2026 at 18:00, 1 hour 48 minutes ago Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
Published on 11/03/2026 at 18:00, 1 hour 48 minutes ago Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote - 31 octobre 2026
Published on 11/03/2026 at 17:45, 2 hours 3 minutes ago Declaration of voting rights at the end of October 2026
Published on 11/03/2026 at 17:45, 2 hours 3 minutes ago Déclaration des droits de vote à fin octobre 2026